Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

AstraZeneca’s Nirsevimab on Track for Priority Review for RSV Prevention in Infants

December 18, 2024
CompanyDrug

Antengene Submits Market Approval Filing for Xpovio in Indonesia for Multiple Myeloma and Lymphoma

December 18, 2024
CompanyDrug

TYK Medicines Receives CDE Approval for CDK7 Inhibitor TY-2699a Clinical Study

December 18, 2024
CompanyDrug

Transcenta Holdings’ TST002 Shows Positive Phase I Results for Bone Density in China

December 18, 2024
CompanyDrug

BeiGene’s Tislelizumab Secures First Approvals Outside China Mainland in Macau

January 6, 2025
CompanyDrug

Yizun Biomedicine’s CNK-UT Cell Therapy Initiates Patient Enrollment for Solid Tumor Trial

December 18, 2024
CompanyDrug

Zelgen Biopharmaceuticals’ Jacktinib Studies Selected for EHA Annual Meeting

December 18, 2024
CompanyDrug

Zelgen Biopharmaceuticals’ ZG0895 Receives FDA Approval for Clinical Trials in Advanced Solid Tumors

December 18, 2024
CompanyDeals

Coherent Biopharma Secures $100 Million in Series B and B+ Financings for Clinical Pipeline

December 18, 2024
CompanyLegal / IP

Philips Agrees to $62 Million Settlement with SEC Over China Marketing Practices

December 18, 2024
CompanyDeals

Drug Farm Secures $27 Million in Series C Financing to Advance HBV Treatments

December 18, 2024
CompanyMedical Device

Peijia Medical Achieves Milestone with First Commercial Implants of Trilogy TAVR System in Hong Kong

December 18, 2024
1 2 … 8 9 10 11 12 … 18 19
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up